Global Pharmaceuticals & Biotech Big Green Snowflakes

Instil Bio

Market Cap: US$172.0m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Sana Biotechnology

Market Cap: US$791.4m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

uniQure

Market Cap: US$1.2b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Rezolute

Market Cap: US$702.9m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Shuttle Pharmaceuticals Holdings

Market Cap: US$3.7m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

Lexeo Therapeutics

Market Cap: US$280.2m

A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Adverum Biotechnologies

Market Cap: US$72.8m

A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.

Leap Therapeutics

Market Cap: US$11.7m

A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

NextCure

Market Cap: US$13.6m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

Immunome

Market Cap: US$801.7m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Scinai Immunotherapeutics

Market Cap: US$2.3m

A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.

OKYO Pharma

Market Cap: US$82.7m

A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

Amarin

Market Cap: US$314.8m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Pasithea Therapeutics

Market Cap: US$5.7m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

Steep Hill

Market Cap: CA$728.0k

Does not have significant operations.

Curis

Market Cap: US$22.6m

A biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.

Titan Pharmaceuticals

Market Cap: US$5.4m

Does not have significant operations.

VivoSim Labs

Market Cap: US$7.7m

A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.

Gain Therapeutics

Market Cap: US$61.5m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Seer

Market Cap: US$118.7m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

GT Biopharma

Market Cap: US$2.7m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Zenas BioPharma

Market Cap: US$919.7m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Novavax

Market Cap: US$1.3b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Synairgen

Market Cap: US$330.8k

Synairgen plc discovers and develops drugs for respiratory diseases.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$427.5m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

Daehan NupharmLtd

Market Cap: ₩97.3b

Manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally.

Original BioMedicals

Market Cap: NT$826.1m

A biotechnology company, chemical entities to solve unmet medical needs in Taiwan.

Betta Pharmaceuticals

Market Cap: CN¥29.5b

Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.

Sinsin Pharmaceutical

Market Cap: ₩87.1b

Manufactures and sells pharmaceutical products in South Korea.

BioLight Life Sciences

Market Cap: ₪24.7m

An ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions.

Guangdong Zhongsheng Pharmaceutical

Market Cap: CN¥17.1b

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Trident Lifeline

Market Cap: ₹3.4b

A pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.

Caregen

Market Cap: ₩2.6t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

Guangdong Jiaying Pharmaceutical

Market Cap: CN¥3.3b

Guangdong Jiaying Pharmaceutical Co., Ltd.

PeterLabs Holdings Berhad

Market Cap: RM 75.7m

An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally.